Trial · NCT02114528
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
NCT02114528, Phase 4, Terminated, Ottawa Heart Institute Research Corporation
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention. Trials, record NCT02114528. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02114528
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
- NCT number
- NCT02114528
- Status
- Terminated
- Phases
- Phase 4
- Enrollment
- 3 participants, actual
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Conditions
- Ventricular Tachycardia, Ventricular Arrhythmia
- Interventions
- Antiarrhythmic Drug Therapy, Catheter ablation
- First posted
- 2014-04-15
- Last updated
- 2026-05-04
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Appropriate ICD therapy | After 30 day treatment period | Appropriate AICD therapy after the 30 day treatment period; defined as ≥ 1 appropriate Shock or ATP that needs further intervention in the form of catheter ablation or AAD therapy. |
| Secondary | Composite Safety Endpoint | Up to 24 months | 1. Catheter ablation arm- procedure related complications, need for concomitant use of AAD (sotalol, mexiletine, propafenone or amiodarone) and/or death. 2. Antiarrhythmic arm- medication side effects, discontinuation of AAD and death, inappropriate shocks from AICD. 3. Slow VT below AICD tachyarrhythmia detection threshold that leads to hospitalization or necessitates catheter ablation 4. Mortality 5. Quality of life score in each treatment arm using the EQ-5D questionnaire 6. Health care resource utilization |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02114528
GET https://conductscience.org/api/trials/v1/NCT02114528/registered